HeartBeam, Inc. (BEAT)
Market Cap | 53.12M |
Revenue (ttm) | n/a |
Net Income (ttm) | -16.91M |
Shares Out | 26.56M |
EPS (ttm) | -0.63 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 98,697 |
Open | 2.090 |
Previous Close | 2.110 |
Day's Range | 2.000 - 2.136 |
52-Week Range | 1.060 - 3.389 |
Beta | -0.98 |
Analysts | Buy |
Price Target | 8.00 (+300.0%) |
Earnings Date | Nov 12, 2024 |
About BEAT
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for BEAT stock is "Buy" and the 12-month stock price forecast is $8.0.
News
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Names Timothy Cruickshank as Chief Financial Officer.
HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Branislav Vajdic - Founder and CEO Rob Eno - President Ravi Malhotra - Senior Director, ...
HeartBeam Reports Second Quarter 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2024 Results.
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time.
HeartBeam Added to Russell Microcap® Index
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Added to Russell Microcap® Index.
Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors
SALT LAKE CITY--(BUSINESS WIRE)--Epitel, a leader in AI technologies for patient-focused brain health solutions, announced today the addition of wearables industry pioneer Ken Nelson to its Board of D...
HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias.
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program.
HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Branislav Vajdic - Founder and CEO Rob Eno - President Rick Brounstein - Consulting Chief Fi...
HeartBeam Reports First Quarter 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2024 Results.
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time.
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias.
HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript
HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results.
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo™ System for Synthesizing a 12-Lead ECG
SANTA CLARA, Calif.--(BUSINESS WIRE)--First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo™ System for Synthesizing a 12-Lead ECG.
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology.
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time.
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights.
HeartBeam, Inc. (BEAT) Q3 2023 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Branislav Vajdic - Chief Executive Officer & Founder Rob Eno - President Rick Brounste...
HeartBeam Reports Third Quarter 2023 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2023 Financial Results.
HeartBeam Announces Expansion of Its Scientific Advisory Board
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Expansion of Its Scientific Advisory Board.
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias.
HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time.
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer
Medical device industry veteran, Jon Hunt, will lead the next phase of growth for Implicity as demand for remote cardiac monitoring and data management solutions soars CAMBRIDGE, Mass. , Sept. 27, 202...
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team.